CFGS
PACB icon

Concourse Financial Group Securities’s Pacific Biosciences PACB Stock Holding History

Concourse Financial Group Securities’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$195 – 2310
2024
Q3 		$170 Hold
100
– – ﹤0.01% 2192
2024
Q2 		$137 Hold
100
– – ﹤0.01% 2260
2024
Q1 		$375 Hold
100
– – ﹤0.01% 2235
2023
Q4 		$981 Sell
100
-20
-17% -$164 ﹤0.01% 2114
2023
Q3 		$1K Sell
120
-111
-48% -$1.27K ﹤0.01% 2099
2023
Q2 		$3.07K Hold
231
– – ﹤0.01% 1943
2023
Q1 		$2.67K Sell
231
-843
-78% -$8.38K ﹤0.01% 2004
2022
Q4 		$8.79K Hold
1,074
– – ﹤0.01% 1699
2022
Q3 		$6K Hold
1,074
– – ﹤0.01% 1615
2022
Q2 		$5K Hold
1,074
– – ﹤0.01% 1848
2022
Q1 		$10K Buy
1,074
+265
+33% +$3.05K ﹤0.01% 1693
2021
Q4 		$17K Sell
809
-1,236
-60% -$29.8K ﹤0.01% 1705
2021
Q3 		$52K Buy
2,045
+47
+2% +$1.39K ﹤0.01% 1286
2021
Q2 		$70K Buy
1,998
+100
+5% +$2.91K ﹤0.01% 1147
2021
Q1 		$63K Buy
1,898
+1,248
+192% +$43.7K ﹤0.01% 1129
2020
Q4 		$17K Buy
+650
New +$11K ﹤0.01% 1522

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Concourse Financial Group Securities's PACB Position: Q4 2024 in Review

Concourse Financial Group Securities sold out of Pacific Biosciences (PACB) in Q4 2024, closing a stake of 100 shares — an estimated $195 sold.

Concourse Financial Group Securities first reported a position in PACB in Q4 2020 and held it in 16 quarters. The position peaked at $70K in Q2 2021. 226 funds tracked by Wall St. Rank hold PACB as of Q4 2024.

  • Concourse Financial Group Securities reported no remaining Pacific Biosciences position as of Q4 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 100 Pacific Biosciences shares in Q4 2024, an estimated $195.
  • Concourse Financial Group Securities first reported a position in Pacific Biosciences in Q4 2020 and held it in 16 quarters.
  • Concourse Financial Group Securities's Pacific Biosciences position peaked at $70K in Q2 2021.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2024.

Based on Concourse Financial Group Securities's 13F filing for Q4 2024, filed 13 Feb 2025.